For Dallas professionals who demand peak performance, B12 optimization isnt optionalits essential
If youve been hesitant to try a new supplement, this is one of the safest and smartest places to start
You can read the abstract at Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial A group of researchers conducted a phase 3 clinical trial to examine the efficacy and safety of subcutaneous semaglutide 2.4 mg once per week, semaglutide 1.0 mg (licensed for the treatment of diabetes), and placebo in managing weight in an adult population who were overweight or obese and have type 2 diabetes
In addition, studies in which weight loss was greater during treatment than in the control group and studies in which lifestyle interventions were continued observed significant weight gain after drug discontinuation
Evidence in humans remains early and limited
Statements Data availability statement The datasets analyzed during the current study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding